Skip to main content
logo
Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.70
+0.05 (0.37%)
Aug 19, 2026, 10:51 AM CST

Original BioMedicals Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.38-0.040.11-
Revenue Growth
----59.81%--
Gross Profit
-0.31-0.040.1-
Operating Income
-104-104.6-78.33-59.26-40.18-32.67
Net Income
-102.24-101.51-75-59.66-40.28-33.88
Earnings Per Share
-1.53-1.53-1.14-1.21-0.86-0.81
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
70.77143.84241.19328.4848.9183.31
Total Debt
9.1611.1911.9816.2419.8920.66
Net Cash (Debt)
61.61132.65229.21312.2429.0262.65
Net Cash Growth
-53.55%-42.13%-26.59%976.08%-53.69%-
Net Cash Per Share
0.922.003.476.330.621.51

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-122.49-96.01-84.11-27.5-30.42-24.93
Capital Expenditures
-0.95-0.95-1.84-0.31-0.47-1.92
Free Cash Flow
-123.44-96.96-85.95-27.81-30.89-26.86
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-80.31%-81.39%88.78%-
Operating Margin
--27453.02%--137818.61%-37547.66%-
Pretax Margin
--26643.04%--138746.51%-37642.06%-
Profit Margin
--26643.05%--138746.51%-37642.06%-
FCF Margin
--25448.29%--64674.42%-28864.49%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-2411.97-27591.987958.93-